With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia||Fred Hutchinson Cancer Research Center / Rebecca Gardner||Young Investigator Grants||2011||Washington|
|Improving Development of and Patient Access to Early Phase Pediatric Cancer Clinical Trials||Seattle Children's Hospital and Regional Medical Center / Russ Geyer||Phase I/II Infrastructure Grants||2010||Washington|
|Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors||Fred Hutchinson Cancer Research Center / Beth Mueller, PhD||Epidemiology Grants||2014||Washington|
|Aberrant DNA methylation in Ewing sarcoma.||Fred Hutchinson Cancer Research Center / Scott Borinstein||Young Investigator Grants||2009||Washington|
|Targeting Novel Pediatric-Specific FLT3 Mutations||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD,PhD||Reach Grants||2015||Washington|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD||Young Investigator Grants||2012||Washington|
|Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML||Fred Hutchinson Cancer Research Center / Phoenix Ho||Young Investigator Grants||2012||Washington|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|